| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.64 | 1e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.59 | 0.0002 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.56 | 0.0005 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |